Akèy › Ensifizyans kadyak › North Carolina
Etid klinik pou Ensifizyans kadyak nan North Carolina
42 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
- Durham26 etid
- Charlotte11 etid
- Asheville7 etid
- Raleigh7 etid
- Greenville6 etid
- Wilmington6 etid
- Greensboro6 etid
- Winston-Salem5 etid
- Statesville4 etid
- Cary3 etid
Tèks ofisyèl etid la (Anglè)
ELEVATE-HFpEF Clinical Study
- Duke University Medical Center, Durham
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06678841Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Asheville
- Research Site, Chapel Hill
- Research Site, Charlotte
- ak 3 plis
Ap rekriteFaz 3
Laj 18 a 130 · Tout sèks · Mizajou Oct 2, 2026 · NCT06307652A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- IMA Clinical Research Lenoir, Lenoir
- Pinehurst Medical Clinic, Inc. - East, Pinehurst
- Piedmont Healthcare, Inc., Statesville
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06935370A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Medication Management, LLC, Greensboro
- WakeMed, Raleigh
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06424288A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Duke University, Durham
Ap rekriteFaz 2
Laj 40 a 84 · Tout sèks · Mizajou Sep 30, 2026 · NCT06979362Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction
- Wake Forest University, Winston-Salem
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06517186HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
- Wake Forest University, Winston-Salem
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05873634A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
- Research Site, Chapel Hill
- Research Site, Durham
- Research Site, Greensboro
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07761117BiVACOR® Total Artificial Heart Early Feasibility Study
- Duke University Hospital, Durham
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT06174103Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
- WakeMed Heart & Vascular - Cary Cardiology, Cary
- Clinical and Translational Research Center - University of North Carolina at Chapel Hill, Chapel Hill
- Duke University Hospital, Durham
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT06736574A Study of LY3971297 in Participants With Heart Failure
- University of North Carolina, Division of Cardiology, Chapel Hill
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT07547540Alleviant ALLAY-HFrEF Study
- Mission Hospital, Asheville
- Duke University Hospital, Durham
- NC Heart and Vascular Research, Raleigh
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06812533Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Asheville Cardiology Associates, Asheville
- Duke University Health System, Durham
- Ima Clinical Research - Lenoir, Lenoir
- ak 2 plis
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- Research Site, Charlotte
- Research Site, Durham
- Research Site, Fayetteville
- ak 6 plis
Ap rekriteFaz 3
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- CON-10318, Charlotte, NC, Charlotte
- Greenville, NC Investigative Site CON-10122, Greenville
- Morrisville, NC Investigative Site CON-10317, Morrisville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06024746A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Greenville, NC Investigative Site 10122, Greenville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Duke University, Durham
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Sanger Heart and Vascular Institute, Charlotte
- Duke University Medical Center, Durham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07069738A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 159, Greensboro
Ap rekriteFaz 2
Laj 30 a 84 · Tout sèks · Mizajou Aug 31, 2026 · NCT07795814Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- Atrium Health Sanger Heart and Vascular Institute, Charlotte
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05677100Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Duke University Health System, Durham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 0 a 20 · Tout sèks · Mizajou Aug 21, 2026 · NCT04278404Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Durham
- Raleigh
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Aug 20, 2026 · NCT00271180A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Focus Clinical Research, Charlotte
- Duke University Health System, Durham
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 19, 2026 · NCT05489705LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
- Tenax Investigational Site, Durham
- Tenax Investigational Site, Winston-Salem
Ap rekriteFaz 3
Laj 18 a 85 · Tout sèks · Mizajou Aug 19, 2026 · NCT07288398A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Peak Clinical Trials, Apex
- Hawthorne Health NC, Concord
- Duke University, Durham
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001Alleviant ALLAY-HF Study
- Mission Hospital, Asheville
- Duke University Hospital, Durham
- NC Heart and Vascular Research, Raleigh
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05685303Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
- Duke University Hospital, Durham
Ap rekriteFaz 2
Laj 0 a 16 · Tout sèks · Mizajou Aug 10, 2026 · NCT06080074CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study
- Sanger Heart and Vascular Institute, Charlotte
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 21, 2026 · NCT06096675A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
- FIN-10318, Charlotte, NC, Charlotte
- Greenville, NC Investigative Site FIN-10122, Greenville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 10, 2026 · NCT06033950PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- UNC Medical Center, Durham
- Duke University, Durham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- University of North Carolina at Chapel Hill, Chapel Hill
- Carolinas Medical Center, Charlotte
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Moses H. Cone Memorial Hospital, Greensboro
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT06699056BOOST: Blended Onsite and Offsite Structured Exercise Training and Coaching
- Wake Forest University Health Sciences, Winston-Salem
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT07413198Splanchnic X: Splanchnic Nerve Block in Heart Failure With Reduced Ejection Fraction
- Duke, Durham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT06733012Developing a Digital Aid to Improve ICD Decisions
- Eastern Carolina University, Greenville
Ap rekrite
Laj 60 ak plis · Tout sèks · Mizajou Apr 27, 2026 · NCT07084142The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
- UNC Eastowne Kidney Transplant Clinic, Chapel Hill
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 14, 2026 · NCT06059664XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
- Duke University Medical Center, Durham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT06895070His-Bundle Corrective Pacing in Heart Failure
- Mission Health, Asheville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT05265520Supporting Health in Veterans With Heart Failure
- VA Clinic - Durham, Durham
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 13, 2025 · NCT05839067Left vs Left Randomized Clinical Trial
- MH Mission Hospital LLLP- Asheville Cardiology Associates, Asheville
- University of North Carolina, Chapel Hill
- Novant Health, Charlotte
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2025 · NCT05650658Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.